# Trade Mark Journal No.2026/005 30 January 2026

## WO0000001896690 (5,42)

Office of origin: United States of America

Date of International Registration:5 December 2025
Date of designation in the UK: 5 December 2025

International priority date claimed: 16 July 2025 (United States of America) (99287857)

Class 5
  Pharmaceutical preparations for the treatment and prevention of cancer and autoimmune disorders and diseases; therapeutic pharmaceuticals for the treatment of cancer and autoimmune disorders and diseases; anti-cancer preparations; immunosuppressive pharmaceutical preparations.
Class 42
  Pharmaceutical research and development; scientific research and development; research and development in the field of medical preparations, drug discovery, oncology, autoimmunity, and immunology.

Cullinan Therapeutics, Inc.

Representative: Malaika D. Tyson Lathrop GPM LLP, 155 N. Wacker Drive, Suite 3800, Chicago IL 60606, UNITED STATES OF AMERICA